Cell-based therapy for epithelial wounds

David T. Harris, Jianhua Hilgaertner, Caitlin Simonson, Richard J. Ablin, Michael Badowski

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background aims. Bone marrow-derived cells (BMDC) form a significant portion of regenerating epithelial tissue. The purpose of this study was to determine whether exogenous BMDC (containing stroma, stem and progenitor cells), introduced systemically or within the injury site, could enhance the injury repair response. Methods. Excisional wounds (10-mm diameter) were treated by systemic (intravenous; i.v.) and local (subcutaneous; s.c.) administration of BMDC (10-20 × 106/100 μL phosphate-buffered saline). Young and aged BMDC and recipients were studied. Results. Young BMDC (2 months old) increased the healing rate compared with older BMDC (1 year old), as measured by the rate of healing and the percentage of healed tissue. Young recipients had statistically better healing efficiency than older recipients. When old BMDC were used, young recipients had a better healing ability than older recipients. In addition, when the size of the healed tissue, the area of repigmentation and hair growth at the injury site were compared, young BMDC and young recipients had superior effects compared with old BMDC and old recipients. Conclusions. These results demonstrate that cellular therapy is important for wound healing in older recipients that do not heal significantly without intervention. BMDC injections result in normal healing, indistinguishable from young recipients. Significantly, a single injection into the wound margin is sufficient to reverse the wounding process and promote normal wound healing. Although younger recipients eventually healed without therapy, BMDC injections accelerated the process, reduced scarring and increased hair regrowth. These findings provide insight into the treatment of non-healing epithelial tissue with BMDC.

Original languageEnglish (US)
Pages (from-to)802-810
Number of pages9
JournalCytotherapy
Volume14
Issue number7
DOIs
StatePublished - Aug 2012

Fingerprint

Cell- and Tissue-Based Therapy
Bone Marrow Cells
Wounds and Injuries
Wound Healing
Injections
Stem Cells
Epithelium
Cicatrix
Therapeutics
Phosphates

Keywords

  • Bone marrow
  • Epithelial tissues
  • Stem cells
  • Wound healing

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Molecular Medicine

Cite this

Harris, D. T., Hilgaertner, J., Simonson, C., Ablin, R. J., & Badowski, M. (2012). Cell-based therapy for epithelial wounds. Cytotherapy, 14(7), 802-810. https://doi.org/10.3109/14653249.2012.671520

Cell-based therapy for epithelial wounds. / Harris, David T.; Hilgaertner, Jianhua; Simonson, Caitlin; Ablin, Richard J.; Badowski, Michael.

In: Cytotherapy, Vol. 14, No. 7, 08.2012, p. 802-810.

Research output: Contribution to journalArticle

Harris, DT, Hilgaertner, J, Simonson, C, Ablin, RJ & Badowski, M 2012, 'Cell-based therapy for epithelial wounds', Cytotherapy, vol. 14, no. 7, pp. 802-810. https://doi.org/10.3109/14653249.2012.671520
Harris DT, Hilgaertner J, Simonson C, Ablin RJ, Badowski M. Cell-based therapy for epithelial wounds. Cytotherapy. 2012 Aug;14(7):802-810. https://doi.org/10.3109/14653249.2012.671520
Harris, David T. ; Hilgaertner, Jianhua ; Simonson, Caitlin ; Ablin, Richard J. ; Badowski, Michael. / Cell-based therapy for epithelial wounds. In: Cytotherapy. 2012 ; Vol. 14, No. 7. pp. 802-810.
@article{68a67e519d5f42728d0f8b0904b2169e,
title = "Cell-based therapy for epithelial wounds",
abstract = "Background aims. Bone marrow-derived cells (BMDC) form a significant portion of regenerating epithelial tissue. The purpose of this study was to determine whether exogenous BMDC (containing stroma, stem and progenitor cells), introduced systemically or within the injury site, could enhance the injury repair response. Methods. Excisional wounds (10-mm diameter) were treated by systemic (intravenous; i.v.) and local (subcutaneous; s.c.) administration of BMDC (10-20 × 106/100 μL phosphate-buffered saline). Young and aged BMDC and recipients were studied. Results. Young BMDC (2 months old) increased the healing rate compared with older BMDC (1 year old), as measured by the rate of healing and the percentage of healed tissue. Young recipients had statistically better healing efficiency than older recipients. When old BMDC were used, young recipients had a better healing ability than older recipients. In addition, when the size of the healed tissue, the area of repigmentation and hair growth at the injury site were compared, young BMDC and young recipients had superior effects compared with old BMDC and old recipients. Conclusions. These results demonstrate that cellular therapy is important for wound healing in older recipients that do not heal significantly without intervention. BMDC injections result in normal healing, indistinguishable from young recipients. Significantly, a single injection into the wound margin is sufficient to reverse the wounding process and promote normal wound healing. Although younger recipients eventually healed without therapy, BMDC injections accelerated the process, reduced scarring and increased hair regrowth. These findings provide insight into the treatment of non-healing epithelial tissue with BMDC.",
keywords = "Bone marrow, Epithelial tissues, Stem cells, Wound healing",
author = "Harris, {David T.} and Jianhua Hilgaertner and Caitlin Simonson and Ablin, {Richard J.} and Michael Badowski",
year = "2012",
month = "8",
doi = "10.3109/14653249.2012.671520",
language = "English (US)",
volume = "14",
pages = "802--810",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Cell-based therapy for epithelial wounds

AU - Harris, David T.

AU - Hilgaertner, Jianhua

AU - Simonson, Caitlin

AU - Ablin, Richard J.

AU - Badowski, Michael

PY - 2012/8

Y1 - 2012/8

N2 - Background aims. Bone marrow-derived cells (BMDC) form a significant portion of regenerating epithelial tissue. The purpose of this study was to determine whether exogenous BMDC (containing stroma, stem and progenitor cells), introduced systemically or within the injury site, could enhance the injury repair response. Methods. Excisional wounds (10-mm diameter) were treated by systemic (intravenous; i.v.) and local (subcutaneous; s.c.) administration of BMDC (10-20 × 106/100 μL phosphate-buffered saline). Young and aged BMDC and recipients were studied. Results. Young BMDC (2 months old) increased the healing rate compared with older BMDC (1 year old), as measured by the rate of healing and the percentage of healed tissue. Young recipients had statistically better healing efficiency than older recipients. When old BMDC were used, young recipients had a better healing ability than older recipients. In addition, when the size of the healed tissue, the area of repigmentation and hair growth at the injury site were compared, young BMDC and young recipients had superior effects compared with old BMDC and old recipients. Conclusions. These results demonstrate that cellular therapy is important for wound healing in older recipients that do not heal significantly without intervention. BMDC injections result in normal healing, indistinguishable from young recipients. Significantly, a single injection into the wound margin is sufficient to reverse the wounding process and promote normal wound healing. Although younger recipients eventually healed without therapy, BMDC injections accelerated the process, reduced scarring and increased hair regrowth. These findings provide insight into the treatment of non-healing epithelial tissue with BMDC.

AB - Background aims. Bone marrow-derived cells (BMDC) form a significant portion of regenerating epithelial tissue. The purpose of this study was to determine whether exogenous BMDC (containing stroma, stem and progenitor cells), introduced systemically or within the injury site, could enhance the injury repair response. Methods. Excisional wounds (10-mm diameter) were treated by systemic (intravenous; i.v.) and local (subcutaneous; s.c.) administration of BMDC (10-20 × 106/100 μL phosphate-buffered saline). Young and aged BMDC and recipients were studied. Results. Young BMDC (2 months old) increased the healing rate compared with older BMDC (1 year old), as measured by the rate of healing and the percentage of healed tissue. Young recipients had statistically better healing efficiency than older recipients. When old BMDC were used, young recipients had a better healing ability than older recipients. In addition, when the size of the healed tissue, the area of repigmentation and hair growth at the injury site were compared, young BMDC and young recipients had superior effects compared with old BMDC and old recipients. Conclusions. These results demonstrate that cellular therapy is important for wound healing in older recipients that do not heal significantly without intervention. BMDC injections result in normal healing, indistinguishable from young recipients. Significantly, a single injection into the wound margin is sufficient to reverse the wounding process and promote normal wound healing. Although younger recipients eventually healed without therapy, BMDC injections accelerated the process, reduced scarring and increased hair regrowth. These findings provide insight into the treatment of non-healing epithelial tissue with BMDC.

KW - Bone marrow

KW - Epithelial tissues

KW - Stem cells

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=84863911213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863911213&partnerID=8YFLogxK

U2 - 10.3109/14653249.2012.671520

DO - 10.3109/14653249.2012.671520

M3 - Article

C2 - 22458955

AN - SCOPUS:84863911213

VL - 14

SP - 802

EP - 810

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 7

ER -